By Sheeba M. | April 13, 2026
Canopy Growth Stock Jumps as New Product Lines Drive Domestic Revenue Growth
Canopy Growth Corporation (CGC) has been one of the most watched names in the cannabis sector for years — and not always for good reasons. After burning through billions in pursuit of a global cannabis empire that never materialized, the Smith Falls-based company is now executing a deliberately narrower strategy: dominate the Canadian recreational market, shed international assets, and preserve cash. The market is starting to take notice.
Revenue Mix Shift Favoring Domestic Strength
In the most recent quarter, Canadian recreational cannabis sales grew 12% sequentially — a meaningful acceleration compared to the flat-to-declining trend in prior periods. The growth was driven by two product categories that have become unexpected winners: premium dried flower and ingestible cannabis oils. Both categories carry better-than-average gross margins and benefit from strong brand loyalty, a rare thing in this commodity-adjacent market.
The company’s Organigram partnership continues to yield licensing revenue, and management has hinted at additional co-development deals in the pipeline. Unlike the failed Acreage acquisition, these smaller partnerships don’t require massive capital outlays upfront.
Balance Sheet Remains the Key Risk
Despite the operational turnaround, Canopy still carries approximately CAD $1.4 billion in debt and has only modest cash reserves relative to its burn rate. The company guided to cash flow breakeven by Q4 2026, but that projection assumes no major regulatory disruptions and continued sequential revenue growth — both of which carry execution risk. For context, compare this to Green Thumb Industries, which generates positive EBITDA while maintaining a disciplined retail expansion pace.
Why Analysts Are Upgrading CGC
A trio of analyst upgrades in the past 30 days has given CGC its first serious bullish case in years. The bull thesis centers on valuation — at roughly 1.2x trailing sales, CGC trades at a steep discount to comparable North American MSOs. If the domestic revenue trend holds and the company avoids any new international missteps, the discount could narrow significantly. The bear case remains unchanged: debt maturity walls, regulatory risk, and the ever-present possibility that Constellation Brands pulls its convertible debt support.
Sources
- Yahoo Finance — CGC Stock Quote & News — Current price, analyst ratings, and financial data
Track cannabis stocks with the Weedstock Real-Time Tracker